Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects

Molecular Oncology

Volumn 8, Issue 1, 2014, Pages 39-49

  Mirnezami, R ^a   Spagou, K ^b   Vorkas, P A ^b   Lewis, M R ^b   Kinross, J ^a   Want, E ^b   Shion, H ^c   Goldin, R D ^a   Darzi, A ^a   Takats, Z ^b   Holmes, E ^b   Cloarec, O ^b,d   Nicholson, J K ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WATERS CORPORATION   (United States)

^d Korrigan Sciences Ltd   (United Kingdom)

Author keywords

Colorectal cancer; Lipid profiling; MALDI MSI; Molecular imaging; Tumour microenvironment

Indexed keywords

ARTICLE; CANCER TISSUE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEASIBILITY STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; LIPIDOMICS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONISATION IMAGING MASS SPECTROMETRY; MOLECULAR IMAGING; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT;

COLORECTAL CANCER; LIPID PROFILING; MALDI-MSI; MOLECULAR IMAGING; TUMOUR MICROENVIRONMENT;

COLON; COLORECTAL NEOPLASMS; HUMANS; LIPIDS; RECTUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MICROENVIRONMENT;

EID: 84892952056     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.08.010     Document Type: Article

References (54)

1. Aichler M., Elsner M., Ludyga N., Feuchtinger A., Zangen V., Maier S.K., et al. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J. Pathol. 2013.
2. Alexandrov T. MALDI imaging mass spectrometry: statistical data analysis and current computational challenges. BMC Bioinfo. 2012, 13(Suppl 16):S11.
3. Azordegan N., Fraser V., Le K., Hillyer L.M., Ma D.W., Fischer G., et al. Carcinogenesis alters fatty acid profile in breast tissue. Mol. Cell Biochem. 2012.
4. Bouslimani A., Bec N., Glueckmann M., Hirtz C., Larroque C. Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Commun. Mass Spectrom. 2010, 24(4):415-421.
5. Caprioli R.M., Farmer T.B., Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem. 1997, 69(23):4751-4760.
6. Casadonte R., Caprioli R.M. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat. Protoc. 2011, 6(11):1695-1709.
7. Cillero-Pastor B., Eijkel G., Kiss A., Blanco F.J., Heeren R.M. Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage. Anal Chem. 2012, 84(21):8909-8916.
8. Cloarec O., Dumas M.E., Trygg J., Craig A., Barton R.H., Lindon J.C., et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem. 2005, 77(2):517-526.
9. Cohen S.L., Chait B.T. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins. Anal Chem. 1996, 68(1):31-37.
10. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867.
11. Djidja M.C., Claude E., Snel M.F., Francese S., Scriven P., Carolan V., et al. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal. Bioanal. Chem. 2010, 397(2):587-601.
12. Doria M.L., Cotrim C.Z., Simoes C., Macedo B., Domingues P., Domingues M.R., et al. Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines. J. Cell Physiol. 2013, 228(2):457-468.
13. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., Pierce S.K. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 2003, 21:457-481.
14. Eberlin L.S., Norton I., Orringer D., Dunn I.F., Liu X., Ide J.L., et al. Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. Proc. Natl. Acad. Sci. U S A 2013, 110(5):1611-1616.
15. Engelhardt J.J., Boldajipour B., Beemiller P., Pandurangi P., Sorensen C., Werb Z., et al. Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. Cancer Cell. 2012, 21(3):402-417.
16. Fernandis A.Z., Wenk M.R. Membrane lipids as signaling molecules. Curr. Opin. Lipidol. 2007, 18(2):121-128.
17. Fonville J.M., Carter C., Cloarec O., Nicholson J.K., Lindon J.C., Bunch J., et al. Robust data processing and normalization strategy for MALDI mass spectrometric imaging. Anal Chem. 2012, 84(3):1310-1319.
18. Gerbig S., Golf O., Balog J., Denes J., Baranyai Z., Zarand A., et al. Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging. Anal Bioanal. Chem. 2012, 403(8):2315-2325.
19. Goto-Inoue N., Hayasaka T., Zaima N., Setou M. Imaging mass spectrometry for lipidomics. Biochim. Biophys. Acta 2011, 1811(11):961-969.
20. Gruner B.M., Hahne H., Mazur P.K., Trajkovic-Arsic M., Maier S., Esposito I., et al. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. PLoS One 2012, 7(6):e39424.
21. Gschwind A., Prenzel N., Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res. 2002, 62(21):6329-6336.
22. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
23. Hart P.J., Francese S., Claude E., Woodroofe M.N., Clench M.R. MALDI-MS imaging of lipids in ex vivo human skin. Anal Bioanal. Chem. 2011, 401(1):115-125.
24. Hogan N.M., Dwyer R.M., Joyce M.R., Kerin M.J. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int. J. Cancer 2012, 131(1):1-7.
25. Huwiler K.G., Mosher D.F., Vestling M.M. Optimizing the MALDI-TOF-MS observation of peptides containing disulfide bonds. J. Biomol. Tech. 2003, 14(4):289-297.
26. Ishikawa S., Tateya I., Hayasaka T., Masaki N., Takizawa Y., Ohno S., et al. Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. PLoS One 2012, 7(11):e48873.
27. Klomp D.W., van de Bank B.L., Raaijmakers A., Korteweg M.A., Possanzini C., Boer V.O., et al. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer. NMR Biomed. 2011, 24(10):1337-1342.
28. Martinez-Outschoorn U.E., Lin Z., Trimmer C., Flomenberg N., Wang C., Pavlides S., et al. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011, 10(15):2504-2520.
29. Meding S., Nitsche U., Balluff B., Elsner M., Rauser S., Schone C., et al. Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J. Proteome Res. 2012, 11(3):1996-2003.
30. Meriaux C., Franck J., Wisztorski M., Salzet M., Fournier I. Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids. J. Proteomics 2010, 73(6):1204-1218.
31. Morgan T.M., Seeley E.H., Fadare O., Caprioli R.M., Clark P.E. Imaging the clear cell renal cell carcinoma proteome. J. Urol. 2013, 189(3):1097-1103.
32. Orr J.W. The relative importance of cell and field in cancer. East Afr. Med. J. 1954, 31(3):101-106.
33. Passarelli M.K., Winograd N. Lipid imaging with time-of-flight secondary ion mass spectrometry (ToF-SIMS). Biochim. Biophys. Acta 2011, 1811(11):976-990.
34. Quehenberger O., Dennis E.A. The human plasma lipidome. N. Engl. J. Med. 2011, 365(19):1812-1823.
35. Rompp A., Guenther S., Takats Z., Spengler B. Mass spectrometry imaging with high resolution in mass and space (HR(2) MSI) for reliable investigation of drug compound distributions on the cellular level. Anal Bioanal. Chem. 2011, 401(1):65-73.
36. Sachfer K.C., Szaniszlo T., Gunther S., Balog J., Denes J., Keseru M., et al. In situ, real-time identification of biological tissues by ultraviolet and infrared laser desorption ionization mass spectrometry. Anal Chem. 2011, 83(5):1632-1640.
37. Sasi-Szabó L., Balog J., Kinross J., Lewis M.R., Muirhead L.J., Veselkov K., et al. The 'Intelligent surgical knife': real-time classification of tumor Chemistry in surgery via Rapid Evaporative ionization mass spectrometry. Sci. Translational Med. 2013, in press.
38. Schwamborn K., Caprioli R.M. Molecular imaging by mass spectrometry-looking beyond classical histology. Nat. Rev. Cancer 2010, 10(9):639-646.
39. Shimma S., Sugiura Y., Hayasaka T., Hoshikawa Y., Noda T., Setou M. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 2007, 855(1):98-103.
40. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6(5):963-968.
41. Smith R.E., Lespi P., Di Luca M., Bustos C., Marra F.A., de Alaniz M.J., et al. A reliable biomarker derived from plasmalogens to evaluate malignancy and metastatic capacity of human cancers. Lipids 2008, 43(1):79-89.
42. Sparvero L.J., Amoscato A.A., Dixon C.E., Long J.B., Kochanek P.M., Pitt B.R., et al. Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations. Chem. Phys. Lipids 2012, 165(5):545-562.
43. Straussman R., Morikawa T., Shee K., Barzily-Rokni M., Qian Z.R., Du J., et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487(7408):500-504.
44. Swartz M.A., Iida N., Roberts E.W., Sangaletti S., Wong M.H., Yull F.E., et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res. 2012, 72(10):2473-2480.
45. Takats Z., Wiseman J.M., Gologan B., Cooks R.G. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 2004, 306(5695):471-473.
46. Takats Z., Denes J., Kinross J. Identifying the margin: a new method to distinguish between cancerous and noncancerous tissue during surgery. Future Oncol. 2012, 8(2):113-116.
47. Tarin D. Clinical and biological implications of the tumor microenvironment. Cancer Microenviron. 2012.
48. Thomas A., Patterson N.H., Marcinkiewicz M.M., Lazaris A., Metrakos P., Chaurand P. Histology-driven data mining of lipid signatures from multiple imaging mass spectrometry analyses: application to human colorectal cancer liver metastasis biopsies. Anal Chem. 2013.
49. Todor I.N., Lukyanova N.Y., Chekhun V.F. The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells. Exp. Oncol. 2012, 34(2):97-100.
50. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007, 6(2):469-479.
51. van Goor H., Gerrits P.O., Grond J. The application of lipid-soluble stains in plastic-embedded sections. Histochemistry 1986, 85(3):251-253.
52. Venkatesh H.S., Chaumeil M.M., Ward C.S., Haas-Kogan D.A., James C.D., Ronen S.M. Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma. Neuro Oncol. 2012, 14(3):315-325.
53. Williams C.M., Maunder K. Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue. Eur. J. Clin. Nutr. 1993, 47(4):260-267.
54. Wilson M., Davies N.P., Grundy R.G., Peet A.C. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours. NMR Biomed. 2009, 22(2):213-219.